ANCA-Associated Vasculitis (AAV)

Episodes 1-6 of 6

• 

  CME/CE Meeting

  Preserving Renal Function in AAV: From Novel Therapies to Practice-Changing Strategies

  June 06, 2025

  Vienna

  Learn more

• 

  MinuteCE®

  Decoding ANCA-Associated Vasculitis (AAV): From Suspicion to Solution

  0.75 credits 6 episodes

  • 

    

    Bernhard Hellmich, MD

  • 

    

    Andreas Kronbichler, MD

  • 

    

    Silke R. Brix, MD, MRCP, SCPR

  0.75 credits 6 episodes

• 

  RestartResume

  Call to Action: Utilizing Avacopan to Improve AAV Care

  RestartResume

  Call to Action: Utilizing Avacopan to Improve AAV Care

  CME/CE

  Call to Action: Utilizing Avacopan to Improve AAV Care

  • 

    

    Stephen McAdoo, MD

• 

  RestartResume

  Elevating AAV Care: Expert Strategies for Optimal Patient Outcomes

  RestartResume

  Elevating AAV Care: Expert Strategies for Optimal Patient Outcomes

  ANCA-Associated Vasculitis (AAV)

  Elevating AAV Care: Expert Strategies for Optimal Patient Outcomes

  • 

    

    Annette Bruchfeld, MD, PhD

  • 

    

    Stephen McAdoo, MD

  • 

    

    Andreas Kronbichler, MD

• 

  RestartResume

  Incorporating Targeted Therapies in Treatment Planning for AAV

  RestartResume

  Incorporating Targeted Therapies in Treatment Planning for AAV

  CME/CE

  Incorporating Targeted Therapies in Treatment Planning for AAV

  • 

    

    David Jayne, MD

  • 

    

    Bernhard Hellmich, MD

• 

  RestartResume

  Case-Based Management of AAV

  RestartResume

  Case-Based Management of AAV

  CME/CE

  Case-Based Management of AAV

  • 

    

    David Jayne, MD

  • 

    

    Annette Bruchfeld, MD, PhD